Effect of macrolides on the expression of HLA-DR and costimulatory molecules on antigen-presenting cells in nasal polyps

Annals of Otology, Rhinology and Laryngology

Volumn 110, Issue 5 I, 2001, Pages 457-463

  Iino, Yukiko ^a   Kojima, Chie ^a   Sasaki, Yukako ^a   Miyazawa, Tetsuo ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atopic predisposition; CD54; CD80; Costimulatory molecule; HLA DR; Macrolide; Macrophage; Nasal polyp

Indexed keywords

B7 ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MACROLIDE;

ADOLESCENT; ADULT; AGED; ANTIGEN PRESENTING CELL; ARTICLE; CELL INFILTRATION; CHILD; CHRONIC SINUSITIS; COMPARATIVE STUDY; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HISTOCOMPATIBILITY COMPLEX; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NOSE POLYP; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035038363     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940111000512     Document Type: Article

References (26)

1. Janeway CA Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994;76:275-85.
2. Guinan EC, Gribben JG, Boussiotis VA, Freeman GJ, Nadler LM. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 1994;84:3261-82.
3. Kuchroo VK, Das MP. Brown JA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995;80:707-18.
4. Yoshimi R, Takamura H, Takasaki K. Antigen presenting cells in nasal mucosa [in Japanese]. J Jpn Soc Immunol Allergol Otolaryngol 1994;12:144-5.
5. Kudoh S, Uetake T, Hagiwara K, et al. Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis [in Japanese]. Jpn J Thorac Dis 1987;25:632-42.
6. Kikuchi S, Suzaki H, Aoki A, Ito O, Nomura Y. Clinical effect of long-term low-dose erythromycin therapy for chronic sinusitis [in Japanese ]. Pracl Otol (Kyoto) 1991;84:41-7.
7. Takagita S, Kitamura H, Nishikawa A, et al. Clinical effect of low-dose erythromycin chemotherapy on chronic sinusitis [in Japanese]. Pract Otol (Kyoto) 1991;84:489-98.
8. lino Y, Sugita K, Toriyama M, Kudo K. Erythromycin therapy forotitis media with effusion in sinobronchial syndrome. Arch Otolaryngol Head Neck Surg 1993;119:648-51.
9. Stoop AE, van der Heijden HAMD, Biewenga J, van der Baan S. Lymphocytes and nonlymphoid cells in human nasal polyps. J Allergy Clin Immunol 1991;87:470-5.
10. lino Y, Toriyama M, Kudo K, Natori Y, Yuo A. Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor alpha production by human monocytes in vitro. Ann Otol Rhinol Laryngol Suppl 1992; 101(suppl 157):16-20.
11. Takeshita K, Yarnagishi I, Harada M, Otomo S, Nakagawa T, Mizushima Y. Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin I production of murine peritoneal macrophages. Drugs Exp Clin Res 1989; 15:527-33.
12. Anderson R, Fernandes AC, Eftychis HE. Studies on the effects of ingestion of a single 500 mg oral dose of erythromycin stearate on leucocyte motility and transformation and on release in vitro of prostaglandin E2 by stimulated leucocytes. J Antimicrob Chemother 1984;14:41-50.
13. Anderson R. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated Superoxide generation and autooxidation. J Infect Dis 1989;159:966-73.
14. Roche Y, Gougerot-Pocidalo MA, Fay M, Forest N, Pocidalo JJ. Macrolides and immunity: effects of erythromycin and spiramycin on human mononuclear cell proliferation. J Antimicrob Chemother 1986; 17:195-203.
15. Miyazawa T, Iino Y. Cell surface antigens on inflammatory cells in the paranasal mucosa of patients alter macrolide therapy [in Japanese]. J Otolaryngol Jpn 1997;100:671-7.
16. Hamilos DL, Leung DYM, Wood R, et al. Evidence tor distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol 1995;96:537-44.
17. Poulter LW, Campbell DA, Mimro C, Janossy G. Discrimination of human macrophages and dendritic cells by means of monoclonal antibodies. Scand J Immunol 1986;24:351-7.
18. +T lymphocytes. J Immunol 1992; 148:1985-92.
19. Damle NK, Klussman K, Linsley PS, Aruffo A, Ledbetter JA. Differential regulatory effects of intercellular adhesion molecule-I on costimulation by the CD28 counter-receptor B7. J Immunol 1992;149:2541-8.
20. Enomoto F, Ichikawa G, Nagaoka I, Yamashita Y. Effect of erythromycin on otitis media with effusion in experimental rat model. Ada Otolaryngol Suppl (Stockh) 1998(suppl 539):57-60.
21. Okubo Y. Macrolides reduce the expression of surface Mac-1 molecule on neutrophil. Kurume Med J 1997;44:115-23.
22. Damle NK, Klussman K, Leytze G, et al. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7. J Immunol 1994;52:2686-97.
23. Iino Y, Okura S, Shiga J, Toriyama M, Kudo K. Histopathological studies on paranasal mucosa from patients treated with erythromycin [in Japanese]. J Otolaryngol Jpn 1994;97: 1070-8.
24. Gajewski TF, Lancki DW, Stack R, Fitch FW. "Anergy" of Th0 helper T lymphocytes induces downregulation of Th1 characteristics and a transition to a Th2-like phenotype. J Exp Med 1994;179:481-91.
25. Ohno I, Lea R, Finotto S, et al. Granulocyte/macrophage colony-stimulating factor (GM-CSF) gene expression by cosino-phils in nasal polyposis. Am J Respir Cell Mol Biol 1991;5:505-10.
26. Bachert C. Cytokines: comparison between polyp tissue, diseased sinus mucosa and normal nasal tissue. In: Mygind N, Lildholdt T, eds. Nasal polyposis: an inflammatory disease and its treatment. Copenhagen, Denmark: Munksgaard. 1997:98-104.